title: Use of monoclonal antibodies to T cells (OKT3) for treatment of acute cellular rejection after renal transplantation.
authors.affiliation: Department of Nephrology, University Hospital, Odense, Denmark.
authors.forename: S A
authors.initials: SA
authors.lastname: Birkeland
authors.forename: V
authors.initials: V
authors.lastname: Svendsen
authors.forename: N
authors.initials: N
authors.lastname: Rohr
authors.forename: B L
authors.initials: BL
authors.lastname: Hansen
authors.forename: A
authors.initials: A
authors.lastname: Elbirk
authors.forename: N
authors.initials: N
authors.lastname: Foged
authors.forename: F
authors.initials: F
authors.lastname: Køhler
mesh_terms: D000293:Adolescent; D000328:Adult; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000276:immunology / Q000627:therapeutic use*; D002648:Child; D006084:Graft Rejection; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation; D008875:Middle Aged; D013601:T-Lymphocytes / Q000145:classification / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents